再鼎医药绩后拉升逾12% 去年营业额按年增近5成 亏损有所收窄

金吾资讯
28 Mar

金吾财讯 | 再鼎医药(09688)绩后股价拉升,截至发稿,涨12.43%,报31.2港元,成交额2.07亿港元。消息面上,据公司业绩公告显示,去年营业额3.98亿元(美元,下同),按年升49.1%。亏损收窄至2.57亿元,上年同期亏损3.35亿元;每股亏损0.26元。不派息。营收方面,产品收入增长主要得益于卫伟迦、则乐及纽再乐的销售额增加。其中则乐收入 1.87 亿美元,同比增长 11%;卫伟迦...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10